Marimed Stock Target Price
| MRMD Stock | USD 0.14 0.01 6.67% |
Marimed fundamentals help investors to digest information that contributes to Marimed's financial success or failures. It also enables traders to predict the movement of Marimed OTC Stock. The fundamental analysis module provides a way to measure Marimed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Marimed otc stock.
Marimed |
Marimed Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Marimed's direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Marimed could also be used in its relative valuation, which is a method of valuing Marimed by comparing valuation metrics of similar companies.Marimed is currently under evaluation in target price category among its peers.
Marimed Fundamentals
| Return On Equity | 0.0303 | |||
| Return On Asset | 0.0921 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 178.51 M | |||
| Shares Outstanding | 339.35 M | |||
| Shares Owned By Insiders | 17.90 % | |||
| Shares Owned By Institutions | 0.81 % | |||
| Price To Earning | 63.75 X | |||
| Price To Book | 2.96 X | |||
| Price To Sales | 1.04 X | |||
| Revenue | 121.46 M | |||
| Gross Profit | 66.26 M | |||
| EBITDA | 28.96 M | |||
| Net Income | 7.22 M | |||
| Cash And Equivalents | 8.44 M | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 448.34 K | |||
| Debt To Equity | 0.35 % | |||
| Current Ratio | 1.33 X | |||
| Book Value Per Share | 0.16 X | |||
| Cash Flow From Operations | 35.85 M | |||
| Earnings Per Share | 0.01 X | |||
| Target Price | 0.98 | |||
| Number Of Employees | 260 | |||
| Beta | 3.06 | |||
| Market Capitalization | 147.62 M | |||
| Total Asset | 123.2 M | |||
| Retained Earnings | (109.57 M) | |||
| Working Capital | (1.18 M) | |||
| Current Asset | 1.98 M | |||
| Current Liabilities | 3.16 M | |||
| Net Asset | 123.2 M |
About Marimed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Marimed's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Marimed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Marimed based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Marimed OTC Stock
Marimed financial ratios help investors to determine whether Marimed OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Marimed with respect to the benefits of owning Marimed security.